Corticosteroid Use in Elderly Patients

Introduction to Corticosteroid Therapy

The American College of Cardiology recommends that systemic corticosteroids should be avoided or limited when possible in elderly patients, with topical or inhaled formulations preferred when feasible, and when systemic therapy is necessary, use the lowest effective dose for the shortest duration with mandatory bone protection and monitoring for cardiovascular, metabolic, and infectious complications 1, 2, 3

Uncontrolled hypertension or heart failure is a contraindication for systemic corticosteroids in elderly patients, as they cause sodium retention and can precipitate or worsen cardiovascular complications 1
The European Hematology Association recommends minimizing steroid exposure in older patients due to increased risk of severe complications including muscle weakness, atrophy, and infections 3

In elderly patients with inflammatory bowel disease, the European Society of Gastrointestinal Endoscopy recommends never using systemic corticosteroids for maintenance therapy, as this is explicitly contraindicated due to lack of efficacy in preventing relapse and high risk of adverse effects 6, 2
Budesonide is strongly preferred over prednisolone for ileocolonic Crohn's disease or left-sided ulcerative colitis in elderly patients due to better safety profile 2, 3

Doses ≥30 mg/day prednisolone for ≥30 days or cumulative ≥5 g over 1 year represent very high fracture risk requiring immediate bone protection with PTH/PTHrP preferred over bisphosphonates 4, 8
Doses ≥20 mg/day for ≥4 weeks require Pneumocystis jirovecii pneumonia prophylaxis with trimethoprim-sulfamethoxazole 8

The American College of Rheumatology recommends assessing hepatic and renal function before initiating corticosteroid therapy in elderly patients 2
The American Geriatrics Society recommends screening for active infections, tuberculosis exposure, and updating vaccinations (pneumococcal, influenza, hepatitis B, herpes zoster) before initiating corticosteroid therapy in elderly patients 8
The National Osteoporosis Foundation recommends obtaining baseline bone mineral density, blood pressure, fasting glucose, and potassium before initiating corticosteroid therapy in elderly patients 8, 4

The American College of Gastroenterology recommends calcium 1000 mg daily and vitamin D 800 IU daily as mandatory for all elderly patients on corticosteroids 8, 6
The American Heart Association recommends proton pump inhibitor or H2-receptor antagonist for gastrointestinal protection, especially critical if combined with NSAIDs 8, 5

The European Respiratory Society recommends topical or inhaled corticosteroids with better safety profiles as first-line when appropriate for the condition 3, 2
The American Gastroenterological Association recommends budesonide formulations over conventional systemic corticosteroids for appropriate indications due to reduced systemic absorption 2, 3

The Endocrine Society recommends never abruptly discontinuing corticosteroids after prolonged use (>3 months) due to risk of Addisonian crisis; taper slowly based on duration of therapy 7, 8
The American College of Rheumatology recommends not delaying bone protection measures—fracture risk increases within 3 months of starting corticosteroids, with greatest bone loss occurring early in treatment 8